Ursodiol can cause side effects such as diarrhea, constipation, dizziness, and back pain. Know more about the treatment options for primary biliary cirrhosis. Your doctor can treat symptoms such ...

Discover why combining simvastatin and rifaximin does not offer a clinically meaningful advantage in preventing severe ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

severe pain in your upper right belly and shoulder. Most cysts may not require treatment, while others may. Learn about polycystic liver disease. An abscess is a pocket within your liver that’s ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

The drug, Journavx, or suzetrigine, was approved to treat moderate to severe acute, or short-term, pain in adults ... such as those with kidney or liver disease, he added. In a report last month by ...

STAT+ subscribers can sign up here to get it delivered to their inbox. Drugs that treat the liver disease known as MASH are enjoying a moment of bliss that is well deserved, long in the making, ...

Each daily consumption of 12 g alcohol increases risk for cirrhosis by 6.2 percent, hepatocellular carcinoma by 11.5 percent. HealthDay News — For patients with hepatitis B virus, alcohol is ...